Published in Am J Transplant on June 22, 2009
Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. Lancet Oncol (2011) 3.36
Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma. Gastroenterology (2010) 2.35
Imaging response in the primary index lesion and clinical outcomes following transarterial locoregional therapy for hepatocellular carcinoma. JAMA (2010) 1.84
Transcatheter intraarterial therapies: rationale and overview. Radiology (2011) 1.59
Intra-arterial treatment with ⁹⁰Y microspheres for hepatocellular carcinoma: 4 years experience at the Ghent University Hospital. Eur J Nucl Med Mol Imaging (2011) 1.50
Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis. J Vasc Interv Radiol (2013) 1.47
Yttrium-90 Radioembolization for Hepatocellular Carcinoma Prior to Liver Transplantation. World J Surg (2017) 1.36
Nonoperative therapies for combined modality treatment of hepatocellular cancer: expert consensus statement. HPB (Oxford) (2010) 1.30
Role of the EASL, RECIST, and WHO response guidelines alone or in combination for hepatocellular carcinoma: radiologic-pathologic correlation. J Hepatol (2010) 1.25
Radiographic response to locoregional therapy in hepatocellular carcinoma predicts patient survival times. Gastroenterology (2011) 1.25
Yttrium 90 radioembolization for the treatment of hepatocellular carcinoma: biological lessons, current challenges, and clinical perspectives. Hepatology (2013) 1.23
2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma. Gut Liver (2015) 1.23
2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma. Korean J Radiol (2015) 1.14
The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations. J Clin Exp Hepatol (2014) 1.12
Efficacy and safety of transarterial radioembolization versus chemoembolization in patients with hepatocellular carcinoma. Cardiovasc Intervent Radiol (2012) 1.09
Updates in the management of hepatocellular carcinoma. Gastroenterol Hepatol (N Y) (2011) 1.07
Radioembolization for hepatocellular carcinoma with portal vein thrombosis: impact of liver function on systemic treatment options at disease progression. J Hepatol (2012) 1.06
Boosted selective internal radiation therapy with 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new personalized promising concept. Eur J Nucl Med Mol Imaging (2013) 0.99
Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: a subgroup analysis. J Hepatol (2012) 0.96
Transarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patients. World J Hepatol (2015) 0.95
Radioembolization of hepatic tumors. J Gastrointest Oncol (2014) 0.94
Interventional therapies for hepatocellular carcinoma. Cancer Imaging (2012) 0.93
Treatment of hepatocellular carcinoma with intra-arterial injection of radionuclides. Nat Rev Gastroenterol Hepatol (2010) 0.93
Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria. Hepatology (2015) 0.92
Management of Hepatocellular Carcinoma: Current Status and Future Directions. Gut Liver (2015) 0.92
Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation. World J Gastroenterol (2013) 0.92
Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols. World J Hepatol (2015) 0.89
Hepatocellular carcinoma: From diagnosis to treatment. World J Hepatol (2015) 0.89
Effective treatment strategies other than sorafenib for the patients with advanced hepatocellular carcinoma invading portal vein. World J Hepatol (2015) 0.89
MRI-monitored transcatheter intra-arterial delivery of SPIO-labeled natural killer cells to hepatocellular carcinoma: preclinical studies in a rodent model. Invest Radiol (2013) 0.88
Consensus for Radiotherapy in Hepatocellular Carcinoma from The 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014): Current Practice and Future Clinical Trials. Liver Cancer (2016) 0.87
18F-fluorodeoxyglucose PET/CT predicts tumour progression after transarterial chemoembolization in hepatocellular carcinoma. Eur J Nucl Med Mol Imaging (2013) 0.87
Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial. Trials (2012) 0.87
Hepatic volume changes induced by radioembolization with 90Y resin microspheres. A single-centre study. Eur J Nucl Med Mol Imaging (2012) 0.87
Image-guided local delivery strategies enhance therapeutic nanoparticle uptake in solid tumors. ACS Nano (2013) 0.87
Presentation and outcomes of hepatocellular carcinoma patients at a western centre. HPB (Oxford) (2011) 0.86
Hepatic radioembolization as a bridge to liver surgery. Front Oncol (2014) 0.85
Chemoembolization and radioembolization for hepatocellular carcinoma. Clin Gastroenterol Hepatol (2013) 0.84
Magnitude of change in alpha-fetoprotein in response to transarterial chemoembolization predicts survival in patients undergoing liver transplantation for hepatocellular carcinoma. Curr Oncol (2013) 0.84
A multidisciplinary approach to the management of hepatocellular carcinoma. Gastroenterol Hepatol (N Y) (2010) 0.84
Transarterial radioembolization for hepatocellular carcinoma: An update and perspectives. World J Gastroenterol (2015) 0.82
Yttrium-90 Selective Internal Radiation Therapy with Glass Microspheres for Hepatocellular Carcinoma: Current and Updated Literature Review. Korean J Radiol (2016) 0.81
Advanced hepatocellular carcinoma and sorafenib: Diagnosis, indications, clinical and radiological follow-up. World J Hepatol (2015) 0.81
Neo-adjuvant therapy for hepatocellular carcinoma before liver transplantation: where do we stand? World J Gastroenterol (2014) 0.81
Effectiveness of Initial Transarterial Chemoembolization for Hepatocellular Carcinoma Among Medicare Beneficiaries. J Natl Compr Canc Netw (2015) 0.81
Update in management of hepatocellular carcinoma in Eastern population. World J Hepatol (2015) 0.81
Hepatocellular carcinoma with macrovascular invasion treated with yttrium-90 radioembolization prior to transplantation. Hepatobiliary Surg Nutr (2017) 0.81
Liver transplantation for hepatobiliary malignancies: a new era of "Transplant Oncology" has begun. Surg Today (2016) 0.81
Comparison of transcatheter arterial chemoembolization and microsphere embolization for treatment of unresectable hepatocellular carcinoma: a meta-analysis. J Cancer Res Clin Oncol (2011) 0.80
Radioembolization for primary and metastatic liver cancer. Semin Radiat Oncol (2011) 0.80
Multidisciplinary management of hepatocellular carcinoma with portal vein tumor thrombus - Eastern Hepatobiliary Surgical Hospital consensus statement. Oncotarget (2016) 0.79
The role of bridging therapy in hepatocellular carcinoma. Int J Hepatol (2013) 0.79
Invasive catheterization of the hepatic artery for preclinical investigation of liver-directed therapies in rodent models of liver cancer. Am J Transl Res (2013) 0.79
Transplantation vs resection for hepatocellular carcinoma with compensated liver function after downstaging therapy. World J Gastroenterol (2013) 0.79
Yttrium-90 microsphere radioembolization for hepatocellular carcinoma. Liver Cancer (2015) 0.78
Current status of multimodal & combination therapy for hepatocellular carcinoma. Indian J Med Res (2012) 0.78
Radioembolisation for treatment of pediatric hepatocellular carcinoma. Pediatr Radiol (2012) 0.78
Role of Transcatheter Intra-arterial Therapies for Hepatocellular Carcinoma. J Clin Exp Hepatol (2014) 0.78
Survival analysis of transarterial radioembolization with yttrium-90 for hepatocellular carcinoma patients with HBV infection. Hepatobiliary Surg Nutr (2014) 0.78
Long-term follow-up study of gastroduodenal lesions after radioembolization of hepatic tumors. World J Gastroenterol (2013) 0.78
Hepatocellular carcinoma: Consensus, controversies and future directions. A report from the Canadian Association for the Study of the Liver Hepatocellular Carcinoma Meeting. Can J Gastroenterol Hepatol (2015) 0.77
Yttrium-90 Radioembolization in Patients with Hepatocellular Carcinoma Who have Previously Received Sorafenib. Front Oncol (2013) 0.77
Localized hyperthermia with iron oxide-doped yttrium microparticles: steps toward image-guided thermoradiotherapy in liver cancer. J Vasc Interv Radiol (2013) 0.77
Radioembolization with Yttrium-90 microspheres in hepatocellular carcinoma: Role and perspectives. World J Hepatol (2015) 0.77
Comparison of outcomes between SBRT, yttrium-90 radioembolization, transarterial chemoembolization, and radiofrequency ablation as bridge to transplant for hepatocellular carcinoma. Adv Radiat Oncol (2015) 0.76
Radioembolisation and portal vein embolization before resection of large hepatocellular carcinoma. World J Gastroenterol (2015) 0.76
Efficacy of combination treatment modalities for intermediate and advanced hepatocellular carcinoma: intra-arterial therapies, sorafenib and novel small molecules. Transl Cancer Res (2013) 0.76
Current status of transarterial radioembolization. World J Radiol (2016) 0.76
Nonsurgical treatment for localized hepatocellular carcinoma. Curr Oncol Rep (2014) 0.76
Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma. Adv Ther (2016) 0.76
Efficacy of External Beam Radiation-Based Treatment plus Locoregional Therapy for Hepatocellular Carcinoma Associated with Portal Vein Tumor Thrombosis. Biomed Res Int (2016) 0.75
Treating hepatocellular carcinoma with (90)Y-bearing microspheres: a review. Biomedicine (Taipei) (2016) 0.75
What's New in Transarterial Therapies for Hepatocellular Carcinoma? Gastrointest Cancer Res (2012) 0.75
Comparing the long-term efficacy of standard and combined minimally invasive procedures for unresectable HCC: a mixed treatment comparison. Oncotarget (2016) 0.75
Confirmation of drug delivery after liver chemoembolization: direct tissue doxorubicin measurement by UHPLC-MS-MS. Biomed Chromatogr (2012) 0.75
Imaging for assessment of treatment response in hepatocellular carcinoma: Current update. Indian J Radiol Imaging (2015) 0.75
LIVER TRANSPLANTATION FOR CARCINOMA HEPATOCELLULAR IN SÃO PAULO: 414 CASES BY THE MILAN/BRAZIL CRITERIA. Arq Bras Cir Dig (2017) 0.75
Novel implications in the treatment of hepatocellular carcinoma. Ann Gastroenterol (2016) 0.75
Radionuclide therapy beyond radioiodine. Wien Med Wochenschr (2012) 0.75
Current status of the organ replacement approach for malignancies and an overture for organ bioengineering and regenerative medicine. Organogenesis (2014) 0.75
How I do it: triaging patients with hepatocellular carcinoma. Semin Intervent Radiol (2012) 0.75
Hepatobiliary scintigraphy may improve radioembolization treatment planning in HCC patients. EJNMMI Res (2017) 0.75
Bridging and downstaging therapy in patients suffering from hepatocellular carcinoma waiting on the list of liver transplantation. Transl Gastroenterol Hepatol (2016) 0.75
Conventional transarterial chemoembolization vs microsphere embolization in hepatocellular carcinoma: a meta-analysis. World J Gastroenterol (2014) 0.75
Selective Internal Radiation Therapy (SIRT) as Conversion Therapy for Unresectable Primary Liver Malignancies. Liver Cancer (2016) 0.75
The role of (90)Y-radioembolization in downstaging primary and secondary hepatic malignancies: a systematic review. Clin Transl Imaging (2016) 0.75
Contemporary strategies in the management of hepatocellular carcinoma. HPB Surg (2012) 0.75
Yttrium-90 Radioembolization of Hepatocellular Carcinoma-Performance, Technical Advances, and Future Concepts. Semin Intervent Radiol (2015) 0.75
Transarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developments. J Hepatocell Carcinoma (2014) 0.75
Loco-regional therapies for patients with hepatocellular carcinoma awaiting liver transplantation: Selecting an optimal therapy. World J Transplant (2016) 0.75
Transarterial radioembolization for hepatocellular carcinoma: a review. J Hepatocell Carcinoma (2016) 0.75
Use of Ethanol in the Trans-Arterial Lipiodol Embolization (TAELE) of Intermediated-Stage HCC: Is This Safer than Conventional Trans-Arterial Chemo-Embolization (c-TACE)? PLoS One (2015) 0.75
Is downstaging prior to liver transplantation important in hepatocellular carcinoma? Am J Transplant (2009) 0.75
A mixed analysis comparing nine minimally invasive surgeries for unresectable hepatocellular carcinoma patients. Oncotarget (2016) 0.75
A Surgical Perspective on Targeted Therapy of Hepatocellular Carcinoma. Diseases (2015) 0.75
Clinical outcomes of Y90 radioembolization for recurrent hepatocellular carcinoma following curative resection. Eur J Nucl Med Mol Imaging (2017) 0.75
Yttrium-90 Radioembolization for Hepatocellular Carcinoma Prior to Liver Transplantation. World J Surg (2017) 0.75
Transarterial Chemoembolization and Radioembolization across Barcelona Clinic Liver Cancer Stages. Semin Intervent Radiol (2017) 0.75
NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017. J Natl Compr Canc Netw (2017) 0.75
Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research. JAMA (1997) 5.47
Bringing global issues to medical teaching. Lancet (2001) 3.65
Evidence for the geographic spread of a methicillin-resistant Staphylococcus aureus clone between Portugal and Spain. J Clin Microbiol (1995) 3.45
Consensus statement on the live organ donor. JAMA (2000) 3.29
Activation and accumulation of B cells in TACI-deficient mice. Nat Immunol (2001) 2.85
Body mass index as a predictor of hepatic steatosis in living liver donors. Liver Transpl (2001) 2.66
ECT and young minds. Lancet (1995) 2.66
Development of Th1-type immune responses requires the type I cytokine receptor TCCR. Nature (2000) 2.51
Reappraisal of the role of axillary lymph node dissection in the conservative treatment of breast cancer. J Clin Oncol (1997) 2.35
Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients. Ann Rheum Dis (2007) 2.22
Biology of sweat glands and their disorders. II. Disorders of sweat gland function. J Am Acad Dermatol (1989) 2.18
Medical malpractice implications of alternative medicine. JAMA (1998) 2.16
Biology of sweat glands and their disorders. I. Normal sweat gland function. J Am Acad Dermatol (1989) 2.09
The effects of sodium ions and potassium ions on glycine uptake by mouse ascites-tumour cells in the presence and absence of selected metabolic inhibitors. Biochem J (1967) 2.09
Large scale association analysis for identification of genes underlying premature coronary heart disease: cumulative perspective from analysis of 111 candidate genes. J Med Genet (2004) 1.94
TACI-ligand interactions are required for T cell activation and collagen-induced arthritis in mice. Nat Immunol (2001) 1.92
CT features of ulcerative colitis and Crohn's disease. AJR Am J Roentgenol (1996) 1.79
Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. Am J Transplant (2007) 1.70
The unrecognized epidemic of blunt carotid arterial injuries: early diagnosis improves neurologic outcome. Ann Surg (1998) 1.67
A study in contrasts: eligibility criteria in a twenty-year sample of NSABP and POG clinical trials. National Surgical Adjuvant Breast and Bowel Program. Pediatric Oncology Group. J Clin Epidemiol (1998) 1.57
DonorNet and the potential effects on organ utilization. Am J Transplant (2010) 1.53
Helical CT in the evaluation of the acute abdomen. AJR Am J Roentgenol (2000) 1.51
Probable succinylcholine-induced rhabdomyolysis in a male athlete. Anesth Analg (1995) 1.49
An unusual avulsion fracture of the proximal tibial epiphysis. Case report and proposed addition to the Watson-Jones classification. Clin Orthop Relat Res (1985) 1.46
Delta and conjugated bilirubin as complementary markers of early rejection in liver-transplant recipients. Clin Chem (1990) 1.44
Tracheobronchial stenting for management of bronchopleural fistula: a novel solution to an old problem. West Indian Med J (2006) 1.41
AIDS and victims of sexual assault. Hosp Community Psychiatry (1992) 1.41
Locating essential Escherichia coli genes by using mini-Tn10 transposons: the pdxJ operon. J Bacteriol (1992) 1.40
Hemodynamic compromise associated with air trapping following coronary artery bypass surgery. Chest (1990) 1.39
The Combitube oesophageal-tracheal double lumen airway for difficult intubation. Can J Anaesth (1993) 1.39
AHPBA/AJCC consensus conference on staging of hepatocellular carcinoma: consensus statement. HPB (Oxford) (2003) 1.39
Intercomparison of dosimetry measurements at the alternating gradient synchrotron from 1986-1988. Health Phys (1993) 1.38
Management of chylothorax by percutaneous catheterization and embolization of the thoracic duct: prospective trial. J Vasc Interv Radiol (1999) 1.37
Urticaria caused by tarantula hairs. Am J Trop Med Hyg (1973) 1.37
Treatment of primary liver graft nonfunction with prostaglandin E1. Transplantation (1989) 1.34
Dermatologic infections in cancer patients treated with epidermal growth factor receptor inhibitor therapy. J Natl Cancer Inst (2009) 1.33
16, 16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection. J Clin Invest (1987) 1.33
Can computerised decision support systems deliver improved quality in primary care?. Interview by Abi Berger. BMJ (1999) 1.31
Intussusception into the enteroanastomosis after Billroth II gastrectomy and Roux-en-Y jejunostomy: sonographic and CT findings. AJR Am J Roentgenol (2001) 1.31
Acute torsion of a wandering spleen: diagnosis by CT and duplex Doppler and color flow sonography. AJR Am J Roentgenol (1991) 1.31
Cholesterol-dependent clustering of IL-2Ralpha and its colocalization with HLA and CD48 on T lymphoma cells suggest their functional association with lipid rafts. Proc Natl Acad Sci U S A (2000) 1.27
Failed primary management of iatrogenic biliary injury: incidence and significance of concomitant hepatic arterial disruption. Surgery (2001) 1.26
Laparoscopic-assisted right lobe donor hepatectomy. Am J Transplant (2006) 1.25
Ethanol and neurotransmitter interactions--from molecular to integrative effects. Prog Neurobiol (1998) 1.23
High fecundity rates following in-vitro fertilization and embryo transfer in antiphospholipid antibody seropositive women treated with heparin and aspirin. Hum Reprod (1994) 1.15
Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E. A preliminary report. J Clin Invest (1989) 1.15
Peripherally inserted central catheters: guidance with use of US versus venography in 2,650 patients. J Vasc Interv Radiol (1999) 1.14
Comparison of endoscopic retrograde cholangiopancreatography with MR cholangiopancreatography in patients with pancreatitis. Radiology (1999) 1.14
Intermittent hypoxia: cell to system. Am J Physiol Lung Cell Mol Physiol (2001) 1.14
The significance of hypotension developing during treadmill exercise testing. Am Heart J (1978) 1.14
Bacteriophage lambda N-dependent transcription antitermination. Competition for an RNA site may regulate antitermination. J Mol Biol (1994) 1.14
Incidence and severity of acute cellular rejection in recipients undergoing adult living donor or deceased donor liver transplantation. Am J Transplant (2008) 1.13
Fibrosis, portal hypertension, and hepatic volume changes induced by intra-arterial radiotherapy with 90yttrium microspheres. Dig Dis Sci (2008) 1.12
Patient attitudes to over-the-counter drugs and possible professional responses to self-medication. Fam Pract (1998) 1.12
Chloroquine-resistant Plasmodium falciparum in eastern Sudan. Acta Trop (1989) 1.12
Traumatic bilateral jugular vein thrombosis: case report and review of the literature. Neurosurgery (1997) 1.08
Increased expression of the epidermal growth factor receptor on human colon carcinoma cells. Arch Surg (1986) 1.08
Serendipitous adrenal masses: prevalence, significance, and management. Am J Surg (1985) 1.06
Endovascular treatment of experimental canine aneurysms: feasibility with MR imaging guidance. Radiology (2000) 1.04
A survey of CMV prevention strategies after liver transplantation. Am J Transplant (2007) 1.03
Treatment of posttraumatic internal carotid arterial pseudoaneurysms with endovascular stents. J Trauma (2000) 1.02
Arthroscopic treatment of meniscal cysts. Arthroscopy (1993) 1.01
Association of UCP2 -866 G/A polymorphism with chronic inflammatory diseases. Genes Immun (2009) 1.01
The impact of uterine fibroid embolization on resumption of menses and ovarian function. J Vasc Interv Radiol (2000) 1.01
Massive spontaneous diaphragmatic rupture in Ehlers-Danlos syndrome. Ann R Coll Surg Engl (2012) 1.00
Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus. J Clin Oncol (2000) 1.00
A genetic animal model of human neocortical heterotopia associated with seizures. J Neurosci (1997) 0.98
Treatment of blunt injury to the carotid artery by using endovascular stents: an early experience. J Neurosurg (1997) 0.98
Structural and functional analyses of the transcription-translation proteins NusB and NusE. J Bacteriol (1995) 0.97
Perception versus reality?: Virtual crossmatch--how to overcome some of the technical and logistic limitations. Am J Transplant (2009) 0.96
Outcomes and native renal recovery following simultaneous liver-kidney transplantation. Am J Transplant (2012) 0.96
Supportive and unsupportive responses of others to rape victims: effects on concurrent victim adjustment. Am J Community Psychol (1991) 0.96
Single-step separation of platelets from whole blood coupled with digital quantification by interfacial platelet cytometry (iPC). Langmuir (2010) 0.95
Laparoscopic live donor nephrectomy--is it safe? Transplantation (2000) 0.95
Changes in the kinetics of muscle contraction in vitamin D-depleted rats. Kidney Int (1978) 0.95
Gastrointestinal infection in the immunocompromised (AIDS) patient. Eur Radiol (2004) 0.95
Standards of medical care based on consensus rather than evidence: the case of routine bedrail use for the elderly. Law Med Health Care (1983) 0.95
Emergency geriatric surgical admissions. Br Med J (1978) 0.95
A prospective trial of primary inguinal hernia repair by surgical trainees. Hernia (2003) 0.94
Acyclovir triphosphate inhibits the diagnostic polymerase chain reaction for cytomegalovirus. Transplantation (1996) 0.94
Using MR imaging to diagnose partial tears of the anterior cruciate ligament: value of axial images. AJR Am J Roentgenol (1997) 0.93
Preoperative angiographic diagnosis of small bowel leiomyomas. Arch Surg (1978) 0.93
Staging of colorectal cancer. Semin Roentgenol (2000) 0.93
Glucocorticoids and mammalian motor nerve excitability. Arch Neurol (1975) 0.93
DNA microarray technology and its applications in dermatology. Exp Dermatol (2004) 0.93
Regeneration of liver with marked fatty change following partial hepatectomy in rats. Dig Dis Sci (2001) 0.92
Medical malpractice litigation: do the British have a better remedy? Am J Law Med (1986) 0.92
MRI appearance of meniscal cysts. Skeletal Radiol (1995) 0.92
alpha 1-antitrypsin deficiency-associated panniculitis: resolution with intravenous alpha 1-antitrypsin administration and liver transplantation. Transplantation (1997) 0.92
Benign and malignant ovarian masses: selection of the most discriminating gray-scale and Doppler sonographic features. Radiology (1998) 0.92
Temsirolimus combined with sorafenib in hepatocellular carcinoma: a phase I dose-finding trial with pharmacokinetic and biomarker correlates. Ann Oncol (2013) 0.91
Further delineation of the DOOR syndrome. Clin Dysmorphol (2000) 0.91
Synergistic effect of 4-hydroperoxycyclophosphamide and etoposide on a human promyelocytic leukemia cell line (HL-60) demonstrated by computer analysis. Cancer Res (1985) 0.90
Predictive value of dobutamine stress echocardiography for coronary artery disease detection in liver transplant candidates. Am J Transplant (2008) 0.90